ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
401 | 59.92099 | 1 | male | 0 | 11 | 30 | Lung Cancer | Cancer | 1 | null | null | 0 | 19,491 | 12,055.1172 | null | 10.5 | black | 26.898438 | 22 | 0.47998 | 0.161987 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 6 | 81 | 20.597656 | 72 | 18 | 36.39844 | 118.35938 | 3.599609 | null | 1.599854 | 130 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.550781 |
402 | 58.11899 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 100 | 40,421 | 20,993.2344 | null | 51 | white | 74 | 112 | 0 | 0 | 3 | 0 | 0 | no | null | null | dnr after sadm | 2 | 15 | 0.899902 | 40 | 20 | 33.09375 | 245 | 2.099609 | 1.399902 | 2.699707 | 127 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.151367 |
403 | 35.25 | 1 | female | 0 | 38 | 1,607 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 271,731 | 130,874.125 | null | 26.75 | white | 33.296875 | 55 | 0.388977 | 0.269958 | 33 | 0 | 0 | yes | null | null | no dnr | 38 | 60 | 6.799805 | 135 | 33 | 39 | 128.875 | 3 | 0.199982 | 5.5 | 133 | 7.519531 | null | null | null | null | null | null | 2.286133 |
404 | 66.18994 | 1 | female | 0 | 12 | 635 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | under $11k | 0 | 53,786 | 28,395.1875 | null | 25 | white | 23.898438 | 27 | 0.779907 | 0.708984 | 3 | 1 | 0 | no | null | null | no dnr | 12 | 113 | 13.099609 | 110 | 20 | 36 | 232.5 | null | null | 1.699951 | 143 | 7.429688 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
405 | 41.02698 | 1 | male | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | under $11k | 37 | 237,244 | 115,715.938 | null | 43 | white | 41.5 | 59 | 0.339966 | 0.224976 | 3 | 0 | 0 | no | 0.8 | 0.7 | dnr after sadm | 16 | 57 | 4 | 120 | 18 | 35.19531 | 175 | null | 9.599609 | 2 | 141 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 3.186035 |
406 | 54.93198 | 0 | male | 0 | 49 | 1,701 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | null | 215,823.25 | null | 27.75 | white | 36 | 46 | 0.431946 | 0.230988 | 3 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 49 | 43 | 8.5 | 120 | 14 | 38.89844 | 763.25 | null | null | 3.799805 | 145 | 7.55957 | null | null | null | null | null | no(M2 and SIP pres) | 2.975586 |
407 | 78.58997 | 1 | male | 1 | 8 | 8 | Colon Cancer | Cancer | 1 | null | null | 9 | 5,871 | 4,175.8438 | null | 6.5 | black | 17.199219 | 24 | 0.761963 | 0.510986 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 73 | 8.699219 | 90 | 20 | 35.59375 | null | null | null | 1 | 144 | null | null | null | null | null | null | <2 mo. follow-up | 3.189941 |
408 | 82.21497 | 1 | male | 0 | 37 | 659 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 10 | $11-$25k | 0 | 135,785 | 73,608.75 | null | 22.25 | white | 22.199219 | 30 | 0.744995 | 0.664917 | 3 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 37 | 63 | 9.398438 | 50 | 14 | 36.59375 | 148 | 3.099609 | 0.899902 | 1.199951 | 143 | 7.509766 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
409 | 40.34198 | 1 | male | 1 | 40 | 40 | MOSF w/Malig | ARF/MOSF | 1 | 16 | >$50k | 26 | 370,093 | 183,324.25 | null | 29.5 | white | 36.796875 | 65 | 0.156982 | 0.076996 | 25 | 0 | 0 | yes | null | null | dnr after sadm | 37 | 57 | 1.299805 | 140 | 16 | 38.69531 | 184 | null | 1.199951 | 5.799805 | 139 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
410 | 60.84097 | 1 | male | 1 | 23 | 23 | CHF | COPD/CHF/Cirrhosis | 1 | 16 | null | 26 | 173,498 | 87,509.5625 | null | 42.666657 | white | 31.398438 | 43 | 0.60791 | 0.419983 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 23 | 63 | 10.699219 | 110 | 18 | 37.09375 | 120 | 2.899902 | 1.099854 | 1.599854 | 136 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.709473 |
411 | 67.82996 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 242,746 | 117,194.312 | null | 46.333313 | white | 32.796875 | 54 | 0.478943 | 0.360962 | 6 | 0 | 0 | yes | null | null | dnr after sadm | 5 | 58 | 9.599609 | 85 | 16 | 39.79688 | 65 | null | null | 5.699219 | 145 | 7.279297 | null | null | null | null | null | <2 mo. follow-up | 2.48584 |
412 | 65.41296 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 86,956 | 41,667.4375 | null | 49 | black | 49 | 99 | 0.141998 | 0.066986 | 4 | 1 | 0 | no | 0.2 | 0.2 | dnr after sadm | 5 | 57 | 19.699219 | 110 | 90 | 34.5 | 87.5 | null | 4.099609 | 2.5 | 133 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 2.554688 |
413 | 74.297 | 0 | male | 0 | 7 | 1,690 | CHF | COPD/CHF/Cirrhosis | 2 | 18 | >$50k | 0 | 19,565 | 10,881.6172 | null | 24 | white | 29.5 | 53 | 0.672974 | 0.501953 | 1 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 7 | 62 | 6.5 | 80 | 18 | 37 | 41 | null | null | 2.099609 | 134 | 7.169922 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
414 | 61.78799 | 0 | female | 0 | 3 | 1,690 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 4,226 | null | null | 12 | black | 21.597656 | 23 | 0.615967 | 0.300964 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 93 | 8.099609 | 106 | 24 | 37 | null | null | 0.299988 | 1.599854 | 129 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.503906 |
415 | 45.43198 | 1 | male | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 2 | 16 | $11-$25k | 0 | 110,902 | 55,334.2188 | null | 47.5 | hispanic | 31.796875 | 57 | 0.426941 | 0.307983 | 18 | 0 | 0 | yes | null | null | dnr after sadm | 7 | 63 | 11.798828 | 120 | 32 | 37.69531 | 92.21875 | 2.299805 | null | 1.699951 | 136 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.460449 |
416 | 62.45297 | 0 | male | 0 | 43 | 1,686 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 0 | 269,517 | 156,722.375 | null | 20 | white | 18.097656 | 26 | 0.886963 | 0.810913 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 43 | 63 | 7.899414 | 100 | 20 | 36.59375 | null | null | null | 1.399902 | 134 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
417 | 70.28094 | 1 | male | 0 | 12 | 659 | Colon Cancer | Cancer | 1 | null | null | 0 | 25,535 | 16,605.7656 | null | 12 | white | 9.599609 | 17 | 0.888916 | 0.747925 | 1 | 0 | 0 | metastatic | null | null | no dnr | 12 | 87 | 20.597656 | 76 | 20 | 36.59375 | null | 4.099609 | 0.799927 | 1.299805 | 137 | null | null | null | null | null | null | null | 2.310547 |
418 | 52.28497 | 0 | female | 0 | 29 | 1,684 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | >$50k | 0 | 303,548 | 185,368.625 | null | 18 | white | 35.796875 | 73 | 0.559937 | 0.447998 | 10 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 29 | 58 | 18.398438 | 170 | 36 | 38.29688 | 173.3125 | 3.799805 | 16.296875 | 1.5 | 141 | 7.479492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
419 | 57.76599 | 1 | male | 0 | 16 | 654 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 30,477 | 18,391.8281 | null | 11 | black | 26.199219 | 36 | 0.810913 | 0.692993 | 1 | 1 | 0 | no | 1 | 0.8 | no dnr | 16 | 80 | 11.398438 | 120 | 28 | 36 | 490.4375 | null | 3.5 | 1.299805 | 136 | 7.55957 | null | null | null | null | null | null | 3.303223 |
420 | 54.74298 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 44 | 79,089 | 41,714.1562 | null | 22 | white | 41.296875 | 55 | 0.023998 | 0.006 | 27 | 0 | 0 | yes | null | null | dnr after sadm | 2 | 72 | 0.049995 | 110 | 32 | 37.89844 | 91.65625 | 2 | null | 0.599976 | 128 | 7.549805 | null | null | null | null | null | <2 mo. follow-up | 3.301758 |
421 | 54.78198 | 1 | male | 0 | 7 | 92 | Lung Cancer | Cancer | 2 | null | null | 0 | 7,383 | 4,346.3086 | null | 7 | black | 17.296875 | 13 | 0.725952 | 0.451965 | 1 | 1 | 0 | metastatic | null | null | no dnr | 7 | 88 | 5.899414 | 114 | 22 | 37.39844 | null | null | null | null | 139 | null | null | null | null | 0 | null | null | 0.4948 |
422 | 46.69998 | 1 | female | 1 | 3 | 3 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 105,684 | 53,072.8438 | null | 41 | other | 66.5 | 88 | 0 | 0 | 19 | 0 | 0 | yes | null | null | dnr after sadm | 2 | 28 | 0.099991 | 135 | 35 | 36.09375 | 51 | null | null | 1.5 | 132 | 7.319336 | null | null | null | null | null | <2 mo. follow-up | 1.842773 |
423 | 36.59097 | 1 | male | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 26 | 80,565 | 38,249.9688 | null | 41.5 | white | 48.695313 | 98 | 0.022999 | 0.004999 | 3 | 0 | 0 | yes | null | null | dnr after sadm | 2 | 58 | 0.5 | 140 | 40 | 38.89844 | 95.375 | 3 | 1.699951 | 2.299805 | 128 | 7.279297 | null | null | null | null | null | <2 mo. follow-up | 2.697266 |
424 | 83.39496 | 0 | male | 0 | 5 | 1,682 | CHF | COPD/CHF/Cirrhosis | 1 | 13 | $11-$25k | 0 | 3,968 | 2,632.3965 | null | 9 | black | 10.599609 | 27 | 0.900879 | 0.833984 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 77 | 5.699219 | 80 | 22 | 37.19531 | null | 4.099609 | 0.699951 | 1.5 | 141 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
425 | 41.29797 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 37 | 182,264 | 94,687.875 | null | 29.333328 | black | 36.195313 | 59 | 0.414978 | 0.294983 | 22 | 1 | 0 | no | 0.8 | 0.75 | dnr after sadm | 18 | 52 | 25.699219 | 140 | 10 | 39 | 282.8125 | 2.599609 | 0.399963 | 4.699219 | 128 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
426 | 90.13794 | 1 | male | 0 | 27 | 53 | MOSF w/Malig | ARF/MOSF | 2 | 24 | null | 44 | 124,700 | 63,788.7812 | null | 23.5 | null | 26.199219 | 61 | 0.184998 | 0.096985 | 26 | 0 | 0 | metastatic | 0 | 0 | dnr before sadm | -5 | 63 | 25.199219 | 65 | 28 | 36.5 | 172.5 | 2 | 2.899902 | 1.799805 | 138 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 5.729492 |
427 | 20.09599 | 1 | female | 0 | 18 | 365 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 51,152 | null | null | 16.666656 | black | 25.5 | 37 | 0.910889 | 0.849976 | 2 | 1 | 0 | no | 1 | 0.75 | no dnr | 18 | 63 | 16.5 | 125 | 32 | 39 | null | null | null | 1.399902 | 130 | null | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
428 | 38.92999 | 0 | male | 0 | 4 | 1,681 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | $25-$50k | 0 | 4,117 | 2,564.5 | null | 5 | white | 23.296875 | 27 | 0.849976 | 0.75293 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 96 | 6.899414 | 92 | 22 | 38.39844 | null | 2.599609 | 8.298828 | 0.799927 | 129 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
429 | 39.81897 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 100 | 79,944 | 41,072.2812 | null | 38 | white | 66 | 105 | 0 | 0 | 16 | 0 | 0 | no | null | null | dnr after sadm | 3 | 23 | 38.09375 | 135 | 48 | 36.39844 | 130 | 4.399414 | 5.699219 | 3.799805 | 138 | 7.199219 | null | null | null | null | null | <2 mo. follow-up | 3.044434 |
430 | 53.09497 | 1 | female | 1 | 6 | 6 | Cirrhosis | COPD/CHF/Cirrhosis | 0 | null | null | 100 | 47,800 | 23,203.7656 | null | 36 | white | 43.898438 | 78 | 0.002 | 0 | 3 | 0 | 0 | no | null | null | dnr after sadm | 1 | 65 | 22.199219 | 195 | 22 | 40 | 150 | null | 34.5 | 2.299805 | 137 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 3.597656 |
431 | 53.38498 | 0 | female | 0 | 13 | 1,676 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 0 | 81,459 | 58,011.0938 | null | 17 | white | 32.296875 | 52 | 0.694946 | 0.603882 | 2 | 0 | 0 | no | null | null | no dnr | 13 | 73 | 5.199219 | 120 | 12 | 38.39844 | 190 | 3.899902 | 0.299988 | 7.399414 | 128 | 7.359375 | null | null | null | null | null | no(M2 and SIP pres) | 2.726563 |
432 | 79.81396 | 1 | male | 0 | 22 | 650 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $25-$50k | 37 | 98,268 | 50,717.0312 | null | 28.666656 | white | 34 | 53 | 0.286987 | 0.176971 | 3 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 102 | 15.898438 | 135 | 12 | 38.5 | 122 | 2.899902 | 2.799805 | 2.699707 | 144 | 7.30957 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.371582 |
433 | 68.45996 | 1 | female | 0 | 11 | 136 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 41 | 26,493 | 14,291.1875 | null | 10 | black | 15.199219 | 16 | 0.720947 | 0.634888 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 1 | 100 | 7.299805 | 60 | 22 | 37.79688 | 222 | null | 0.799927 | 0.699951 | 138 | 7.469727 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.908203 |
434 | 52.52597 | 1 | female | 0 | 8 | 1,206 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 20,605 | 12,221.1406 | null | 15 | black | 17.398438 | 28 | 0.912964 | 0.852905 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 8 | 63 | 6 | 65 | 20 | 36.39844 | 400 | 4 | 0.399963 | 2.699707 | 136 | 7.339844 | null | null | null | 6 | 3 | adl>=4 (>=5 if sur) | 3 |
435 | 62.50198 | 1 | male | 0 | 4 | 595 | CHF | COPD/CHF/Cirrhosis | 4 | 4 | $11-$25k | 0 | 8,761 | 5,023.8125 | null | 7 | hispanic | 17.699219 | 26 | 0.889893 | 0.814941 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 70 | 9.298828 | 60 | 20 | 36 | 352.375 | null | 0.299988 | 1.5 | 138 | 7.449219 | null | null | null | null | null | null | 2.504395 |
436 | 57.02899 | 1 | male | 0 | 27 | 45 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 17 | $11-$25k | 26 | 145,874 | 74,736.375 | null | 30 | white | 27.199219 | 44 | 0.462952 | 0.260986 | 2 | 0 | 0 | yes | 0.5 | 0 | dnr after sadm | 17 | 67 | 5.099609 | 130 | 25 | 37 | 212.5 | 2.5 | 8.398438 | 1.099854 | 136 | 7.55957 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
437 | 61.448 | 1 | male | 0 | 8 | 608 | CHF | COPD/CHF/Cirrhosis | 3 | 3 | under $11k | 0 | 13,444 | 7,088.8398 | null | 12 | black | 12.898438 | 20 | 0.924927 | 0.873901 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 8 | 117 | 7 | 82 | 28 | 36.59375 | 428.5625 | 3.899902 | 1.099854 | 1.199951 | 139 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
438 | 87.76697 | 1 | female | 0 | 28 | 57 | COPD | COPD/CHF/Cirrhosis | 1 | 16 | under $11k | 37 | 109,552 | 53,782.9062 | null | 25.25 | white | 31.796875 | 54 | 0.243988 | 0.084991 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 1 | 55 | 23.796875 | 165 | 36 | 37.79688 | 273.3125 | 3 | null | 0.5 | 143 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 4.458984 |
439 | 65.71399 | 1 | male | 1 | 6 | 6 | Coma | Coma | 2 | null | null | 55 | 45,707 | 21,547.7344 | null | 37 | white | 41.296875 | 72 | 0.032997 | 0.014999 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 5 | 43 | 14.898438 | 80 | 26 | 38.89844 | 174 | null | 9.898438 | 7.699219 | 137 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.753418 |
440 | 46.97098 | 0 | female | 0 | 4 | 1,666 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 5,975 | 3,269.1504 | null | 8 | hispanic | 13.5 | 9 | 0.954956 | 0.922974 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 112 | 8.199219 | 72 | 20 | 37.59375 | 238.09375 | null | null | 0.799927 | 139 | 7.419922 | null | null | null | 2 | null | null | 1.839 |
441 | 62.10797 | 1 | male | 0 | 11 | 664 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 22,091 | 13,650.9375 | null | 11.5 | white | 13.298828 | 16 | 0.921997 | 0.868896 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 11 | 95 | 5.5 | 75 | 22 | 36 | null | 3.899902 | null | 1.299805 | 138 | null | null | null | null | 2 | 5 | SIP>=30 | 5 |
442 | 81.99896 | 1 | female | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 41 | 117,689 | 53,773.375 | null | 27 | white | 25.296875 | 37 | 0.481995 | 0.363953 | 5 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 13 | 65 | 31.199219 | 50 | 26 | 36.79688 | 331.375 | 3.799805 | 1.099854 | 1.899902 | 133 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 3.946777 |
443 | 62.53 | 1 | female | 0 | 16 | 130 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 16,862 | 10,397.3203 | null | 10.666664 | white | 12.699219 | 7 | 0.870972 | 0.709961 | 1 | 0 | 0 | metastatic | 0.85 | 0.9 | no dnr | 16 | 97 | 5.099609 | 96 | 20 | 37.39844 | 342.8125 | 3.799805 | 0.799927 | 0.799927 | 134 | 7.489258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
444 | 54.52197 | 0 | female | 0 | 145 | 1,664 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | >$50k | 0 | 414,803 | null | null | 17 | white | 38.796875 | 54 | 0.579956 | 0.385986 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 145 | 37 | 7.5 | 90 | 24 | 36.29688 | 122.5 | 3.399902 | 1.599854 | 1.399902 | 135 | 7.469727 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
445 | 49.87 | 1 | male | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 59,913 | 29,431.5938 | null | 46 | white | 47.796875 | 94 | 0.084 | 0.031998 | 2 | 0 | 0 | yes | null | null | dnr after sadm | 4 | 57 | 0.099991 | 165 | 28 | 41.19531 | 85 | 2.5 | 2.099609 | 1.699951 | 133 | 7.30957 | null | null | null | null | null | <2 mo. follow-up | 2.226563 |
446 | 61.69199 | 1 | female | 0 | 25 | 292 | Colon Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 75,618 | 41,915.4688 | null | 10.5 | white | 17.199219 | 32 | 0.819946 | 0.610962 | 1 | 0 | 0 | metastatic | 0.85 | 0.7 | no dnr | 25 | 103 | 10.398438 | 106 | 24 | 38.19531 | null | 3.799805 | 0.299988 | 2.399902 | 141 | null | null | null | null | 6 | null | no(M2 and SIP pres) | 4.527397 |
447 | 39.14899 | 1 | female | 0 | 37 | 945 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 147,711 | null | null | 24 | black | 22.5 | 31 | 0.901978 | 0.835938 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 37 | 58 | 6.199219 | 105 | 34 | 36.69531 | null | null | 0.799927 | 0.899902 | 130 | null | null | null | null | 5 | 4 | null | 4 |
448 | 50.45599 | 1 | female | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 202,111 | 102,048.125 | null | 46.5 | white | 41.5 | 71 | 0.136993 | 0.063995 | 29 | 0 | 0 | yes | null | null | dnr after sadm | 5 | 63 | 0.899902 | 115 | 16 | 38.19531 | 89.21875 | 2.799805 | 4.199219 | 2.399902 | 143 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 2.55957 |
449 | 50.57599 | 0 | female | 0 | 46 | 1,657 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 303,934 | 139,610.125 | null | 32.5 | white | 40.898438 | 74 | 0.381958 | 0.185974 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 46 | 55 | 5.299805 | 75 | 12 | 36.19531 | 443.3125 | 2.199707 | 44.398438 | 5.099609 | 147 | 7.229492 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
450 | 68.80798 | 1 | female | 0 | 4 | 870 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 7,354 | 4,315.8477 | null | 8 | black | 20.898438 | 25 | 0.839966 | 0.736938 | 1 | 1 | 0 | no | 0.95 | 0.85 | no dnr | 4 | 94 | 5.399414 | 84 | 20 | 36.39844 | 576 | null | null | 1.699951 | 128 | 7.459961 | null | null | null | 4 | null | SIP>=30 | 3.183199 |
451 | 46.07797 | 1 | male | 0 | 41 | 313 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 18 | >$50k | 44 | 353,422 | 190,804 | null | 35.5 | white | 50 | 72 | 0.003 | 0 | 2 | 0 | 0 | metastatic | null | null | no dnr | 41 | 63 | 3.599609 | 170 | 10 | 35.29688 | 160 | 3.599609 | 51.296875 | 5 | 147 | 7.589844 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
452 | 79.16498 | 0 | female | 0 | 3 | 1,655 | CHF | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 3,974 | 2,517.9512 | null | 8 | white | 14.099609 | 21 | 0.881958 | 0.802979 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 3 | 139 | 6.199219 | 76 | 24 | 36.39844 | 466.625 | null | null | 1 | 141 | 7.459961 | null | null | null | null | null | null | 2.249512 |
453 | 81.758 | 1 | female | 0 | 15 | 36 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 22,800 | 13,578.2578 | null | 8.666664 | white | 20.898438 | 41 | 0.792969 | 0.666992 | 1 | 0 | 0 | no | 0.6 | 0.216 | no dnr | 15 | 110 | 11.199219 | 80 | 24 | 36.39844 | 285.6875 | null | 0.299988 | 1.599854 | 128 | 7.519531 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
454 | 76.98798 | 0 | female | 0 | 36 | 1,655 | COPD | COPD/CHF/Cirrhosis | 0 | 16 | null | 0 | 113,045 | null | null | 10.25 | white | 37.195313 | 51 | 0.380981 | 0.184998 | 2 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 7 | 48 | 12.099609 | 170 | 28 | 36.5 | 155 | null | null | 0.599976 | 134 | 7.40918 | null | null | null | null | 5 | null | 5 |
455 | 81.66498 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 17 | $11-$25k | 41 | 31,827 | 16,880.5469 | null | 22 | white | 17.398438 | 19 | 0.701904 | 0.611938 | 3 | 0 | 0 | no | 0.7 | 0.6 | dnr after sadm | 2 | 97 | 22.097656 | 100 | 24 | 38.39844 | 225.6875 | null | null | 1 | 135 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.646484 |
456 | 54.26999 | 0 | male | 0 | 13 | 1,654 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | under $11k | 0 | 44,608 | 22,993.125 | null | 15 | white | 33.296875 | 46 | 0.669922 | 0.573975 | 2 | 0 | 0 | no | null | null | no dnr | 13 | 107 | 7.099609 | 125 | 28 | 36 | 120.40625 | null | 1.199951 | 2.299805 | 138 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
457 | 22.825 | 1 | male | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 0 | 254,601 | 115,477.625 | null | 49.5 | white | 53.195313 | 80 | 0.004 | 0 | 29 | 0 | 0 | metastatic | null | null | dnr after sadm | 10 | 43 | 2.899902 | 145 | 28 | 38.69531 | 146 | null | 6.5 | 4.299805 | 139 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 2.966309 |
458 | 58.43698 | 1 | female | 0 | 11 | 271 | Colon Cancer | Cancer | 1 | 20 | >$50k | 0 | 14,670 | 9,659.4062 | null | 8 | white | 13.298828 | 19 | 0.869995 | 0.708984 | 1 | 0 | 0 | metastatic | 0.75 | 0.25 | dnr after sadm | 2 | 65 | 7.199219 | 72 | 12 | 37 | null | 3.799805 | 0.699951 | 0.699951 | 135 | null | null | null | null | 2 | null | null | 1.839 |
459 | 58.28598 | 1 | male | 0 | 10 | 872 | Colon Cancer | Cancer | 1 | 14 | >$50k | 0 | 24,073 | 15,612.7109 | null | 11 | white | 3.799805 | 9 | 0.937988 | 0.852905 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 10 | 81 | 11.798828 | 72 | 22 | 38.89844 | null | 4.399414 | 0.599976 | 1 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
460 | 84.29297 | 1 | female | 0 | 3 | 1,291 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,110 | 3,391.9277 | null | 14 | white | 21.597656 | 22 | 0.770996 | 0.634888 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 3 | 103 | 9.398438 | 130 | 20 | 36 | 423.75 | null | null | 1.299805 | 137 | 7.609375 | null | null | null | null | null | null | 3.057129 |
461 | 47.01999 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 44 | 56,169 | 28,008.9219 | null | 31 | white | 49.398438 | 73 | 0.088989 | 0.034996 | 2 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 9 | 28 | 10 | 110 | 26 | 36.29688 | 148.3125 | null | null | 12 | 149 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 3.171875 |
462 | 42.28897 | 0 | female | 0 | 6 | 1,649 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 15 | $11-$25k | 0 | 6,057 | 3,922.8438 | null | 5 | white | 21.796875 | 38 | 0.852905 | 0.756958 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 6 | 70 | 2.599609 | 72 | 20 | 37 | null | 2.799805 | 11.898438 | 0.899902 | 133 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
463 | 86.37097 | 0 | male | 0 | 14 | 1,649 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 14,836 | 9,444.3281 | null | 6.666664 | white | 18.296875 | 32 | 0.812988 | 0.696899 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 14 | 107 | 4.299805 | 80 | 20 | 36.79688 | null | 3.599609 | 0.699951 | 2.5 | 135 | null | null | null | null | null | null | null | 4.03125 |
464 | 72.23499 | 1 | male | 0 | 10 | 579 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | >$50k | 0 | 23,972 | 13,201.7969 | null | 13 | white | 32.796875 | 37 | 0.60498 | 0.498962 | 1 | 1 | 0 | no | 0.5 | 0.2 | dnr after sadm | 1 | 95 | 6.099609 | 98 | 26 | 37.79688 | 83.32812 | 3 | 1.399902 | 1.899902 | 157 | 7.439453 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
465 | 85.35199 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 239,683 | 122,276.312 | null | 41.5 | white | 63.09375 | 95 | 0 | 0 | 26 | 0 | 0 | no | 0.05 | 0.000125 | dnr before sadm | -1 | 33 | 14 | 120 | 35 | 35.89844 | 170 | 3.799805 | 35.695313 | 2.599609 | 137 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
466 | 49.13898 | 1 | female | 0 | 12 | 85 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 17,775 | 10,275.0859 | null | 9 | black | 26.597656 | 35 | 0.523926 | 0.201996 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | dnr after sadm | 2 | 55 | 9.099609 | 122 | 28 | 38.29688 | null | null | null | 0.699951 | 129 | null | null | null | null | 3 | 5 | adl>=4 (>=5 if sur) | 5 |
467 | 79.04395 | 1 | female | 1 | 15 | 15 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 36,520 | 16,195.8438 | null | 11.333328 | white | 25.898438 | 51 | 0.615967 | 0.429993 | 1 | 0 | 0 | yes | 0.6 | 0.4 | dnr after sadm | 2 | 120 | 9.298828 | 110 | 26 | 36.39844 | 110 | 3.699707 | null | 0.899902 | 139 | 7.179688 | null | null | null | null | null | <2 mo. follow-up | 4.448242 |
468 | 41.61798 | 1 | male | 1 | 19 | 19 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 37 | 161,755 | 71,957.1875 | null | 30.333328 | white | 33.09375 | 59 | 0.324951 | 0.210999 | 1 | 0 | 0 | yes | 0.2 | 1 | dnr after sadm | 9 | 127 | 3.199707 | 200 | 38 | 36.39844 | 179 | null | 2.5 | 1.199951 | 149 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 2.968262 |
469 | 25.49199 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 26 | 359,124 | 168,043.625 | null | 31 | white | 42.296875 | 55 | 0.061996 | 0.021 | 80 | 0 | 0 | yes | 0.2 | 0.2 | dnr after sadm | 3 | 103 | 2.799805 | 145 | 46 | 39 | 109.32812 | null | 3.099609 | 1.099854 | 125 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.663086 |
470 | 50.754 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 100 | 448,431 | 236,295.25 | null | 33 | white | 43 | 59 | 0.009998 | 0.002 | 27 | 0 | 0 | no | 0.25 | 0.25 | dnr after sadm | 13 | 42 | 10.699219 | 118 | 12 | 38.89844 | 270 | 3.599609 | 13.699219 | 1.699951 | 131 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 3.865723 |
471 | 53.09198 | 0 | female | 0 | 7 | 1,642 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 13,434 | 6,912.5508 | null | 8 | white | 28.699219 | 35 | 0.679932 | 0.510986 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 7 | 66 | 13.199219 | 102 | 20 | 36.59375 | null | 2.399902 | 5.299805 | 1.199951 | 124 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
472 | 75.80798 | 1 | male | 0 | 26 | 29 | Lung Cancer | Cancer | 2 | 3 | >$50k | 26 | 73,798 | 39,726.125 | null | 10.5 | white | 38 | 78 | 0.030998 | 0 | 3 | 0 | 0 | metastatic | 0.4 | 0.05 | dnr after sadm | 12 | 137 | 29.199219 | 160 | 56 | 38 | 146 | 2.799805 | null | 1.099854 | 143 | 7.469727 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
473 | 75.99695 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | $11-$25k | 0 | 99,364 | 46,090.7812 | null | 53 | white | 42.898438 | 81 | 0.244995 | 0.141998 | 3 | 0 | 0 | no | null | null | dnr after sadm | 6 | 52 | 23.296875 | 150 | 44 | 37 | 170 | null | 3.899902 | 4.5 | 134 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
474 | 54.491 | 0 | male | 0 | 6 | 1,638 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 9,974 | 5,706.2227 | null | 10 | white | 24.5 | 25 | 0.750977 | 0.605957 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 6 | 95 | 6.899414 | 78 | 18 | 36.39844 | null | 2.399902 | 5.599609 | 0.899902 | 125 | null | null | null | null | null | null | null | 3.331055 |
475 | 27.51799 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 37 | 132,130 | 64,562.0938 | null | 46 | hispanic | 34.09375 | 81 | 0.202972 | 0.109985 | 20 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 5 | 76 | 2.799805 | 200 | 56 | 38.39844 | 277 | null | 1.399902 | 2.699707 | 136 | 7.289062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
476 | 59.62198 | 1 | male | 0 | 4 | 274 | Lung Cancer | Cancer | 2 | 12 | >$50k | 0 | 11,765 | 5,337.5898 | null | 10 | white | 19.898438 | 15 | 0.660889 | 0.358948 | 1 | 1 | 0 | metastatic | 1 | 0.5 | no dnr | 4 | 96 | 11.699219 | 104 | 20 | 36.19531 | null | null | null | 1.199951 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
477 | 78.12695 | 1 | female | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 100 | 107,073 | 49,515.3125 | null | 34.666657 | white | 25.5 | 44 | 0.242981 | 0.140991 | 2 | 0 | 1 | no | 0 | 0 | no dnr | 23 | 60 | 24.097656 | 70 | 44 | 38.89844 | 96.65625 | 2 | null | 1.099854 | 141 | 7.429688 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
478 | 30.023 | 0 | male | 0 | 17 | 1,636 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | $25-$50k | 0 | 108,131 | 52,857.5625 | null | 24.666656 | white | 24 | 16 | 0.888916 | 0.848999 | 2 | 0 | 0 | no | null | null | no dnr | 17 | 97 | 4.899414 | 110 | 12 | 38.59375 | 267.5 | 3.099609 | 5.799805 | 1.099854 | 141 | 7.439453 | null | null | null | null | null | no(M2 and SIP pres) | 2.086914 |
479 | 52.70099 | 1 | female | 0 | 4 | 370 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 6,521 | 4,240.2422 | null | 6 | white | 5.699219 | 9 | 0.884888 | 0.737915 | 1 | 0 | 0 | metastatic | 0.7 | 0.15 | no dnr | 4 | 80 | 9.199219 | 64 | 20 | 36.39844 | null | 4.299805 | 0.399963 | 1 | 140 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
480 | 52.767 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 0 | 45,767 | 22,561.2812 | null | 16 | black | 29.699219 | 47 | 0.764893 | 0.689941 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 77 | 17.097656 | 115 | 24 | 38.19531 | 208.5625 | 3.399902 | 4 | 5.399414 | 145 | 7.449219 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
481 | 50.38199 | 0 | female | 0 | 14 | 1,629 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 25,748 | 15,329.3125 | null | 9.666664 | black | 18.796875 | 9 | 0.906982 | 0.843994 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 14 | 60 | null | 50 | 20 | 36.09375 | null | null | null | 0.799927 | 138 | null | null | null | null | 0 | 5 | adl>=4 (>=5 if sur) | 5 |
482 | 37.336 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 168,270 | 83,700.5 | null | 48 | other | 39.695313 | 80 | 0.205994 | 0.112 | 23 | 0 | 0 | yes | 0.8 | 0.8 | dnr after sadm | 3 | 57 | 1.899902 | 140 | 14 | 38.5 | 231.65625 | 3.299805 | 7.5 | 5.699219 | 145 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 2.454102 |
483 | 65.57697 | 1 | male | 0 | 10 | 12 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 42,780 | 20,734.2188 | null | 19.5 | white | 20.296875 | 38 | 0.827881 | 0.718994 | 5 | 0 | 0 | no | null | null | no dnr | 10 | 52 | 3.799805 | 70 | 30 | 38.29688 | 251.40625 | null | null | 1.5 | 142 | 7.529297 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
484 | 42.29398 | 1 | male | 1 | 5 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 44 | 49,389 | 24,999.875 | null | 37 | white | 39.195313 | 73 | 0.244995 | 0.085999 | 3 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 5 | 67 | 23.597656 | 130 | 32 | 36.5 | 167.5 | 3.199707 | 8 | 2.599609 | 134 | 7.529297 | null | null | null | null | null | <2 mo. follow-up | 3.955078 |
485 | 55.31799 | 1 | female | 0 | 12 | 68 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 16,717 | 9,094.3281 | null | 7 | white | 25.398438 | 24 | 0.728882 | 0.575928 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 12 | 120 | 7.5 | 80 | 18 | 37.59375 | null | 2.5 | 3.699707 | 0.599976 | 121 | null | null | null | null | 2 | null | null | 1.839 |
486 | 51.89899 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 61 | 85,777 | 39,979 | null | 23 | null | 35.695313 | 40 | 0.026997 | 0.007 | 14 | 0 | 0 | metastatic | null | null | dnr before sadm | -9 | 40 | 3.799805 | 120 | 34 | 38.19531 | null | null | null | null | 138 | null | null | null | null | null | null | <2 mo. follow-up | 3.771973 |
487 | 48.98599 | 1 | male | 1 | 16 | 16 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 131,400 | 60,309.4688 | null | 38 | white | 29.296875 | 50 | 0.644897 | 0.465942 | 5 | 0 | 0 | no | null | null | dnr after sadm | 10 | 60 | 16.398438 | 115 | 36 | 38 | 132 | 2.399902 | 4.199219 | 1 | 138 | 7.549805 | null | null | null | null | null | <2 mo. follow-up | 3.510742 |
488 | 76.33398 | 1 | male | 0 | 11 | 93 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 24,988 | 13,437.4375 | null | 19 | white | 14.699219 | 32 | 0.882935 | 0.804932 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 60 | 5.799805 | 72 | 20 | 36.19531 | null | 4 | 2.099609 | 1.5 | 144 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
489 | 24.493 | 0 | male | 0 | 37 | 1,619 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 149,776 | 73,399.875 | null | 28 | white | 28.898438 | 41 | 0.836914 | 0.780884 | 5 | 0 | 0 | no | 0.98 | 0.98 | no dnr | 37 | 108 | 29.796875 | 140 | 10 | 38.69531 | 394.25 | 2.299805 | 7.599609 | 0.799927 | 132 | 7.449219 | null | null | null | null | 0 | SIP>=30 | 0 |
490 | 70.46698 | 1 | female | 0 | 14 | 717 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $25-$50k | 9 | 57,539 | 31,008.5938 | null | 14.333328 | other | 32.398438 | 50 | 0.517944 | 0.401978 | 5 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 14 | 135 | 5.099609 | 120 | 26 | 37.69531 | 195.90625 | null | null | 2.299805 | 128 | 7.439453 | null | null | null | null | null | null | 3.690918 |
491 | 58.31897 | 1 | male | 0 | 87 | 98 | MOSF w/Malig | ARF/MOSF | 1 | 23 | null | 26 | 542,326 | null | null | 41 | white | 33.898438 | 40 | 0.295959 | 0.184998 | 2 | 0 | 0 | yes | 0.4 | 0.1 | dnr before sadm | -1 | 112 | 4.299805 | 205 | 15 | 37.69531 | 52 | 3.399902 | 1.899902 | 0.899902 | 137 | 7.279297 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.641602 |
492 | 80.25494 | 1 | female | 1 | 5 | 5 | Coma | Coma | 2 | null | null | 94 | 14,297 | 6,564.4648 | null | 19 | white | 23.398438 | 34 | 0.118988 | 0.07399 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 4 | 127 | 13.599609 | 135 | 32 | 38.89844 | 357.125 | null | null | 0.599976 | 138 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 3.553223 |
493 | 67.58398 | 1 | male | 0 | 4 | 482 | Lung Cancer | Cancer | 3 | 12 | $11-$25k | 0 | 10,819 | 5,204.7305 | null | 17 | black | 17.699219 | 18 | 0.687988 | 0.395996 | 1 | 0 | 0 | metastatic | 0.6 | 0.3 | no dnr | 4 | 97 | 12 | 80 | 20 | 35.79688 | null | null | null | 1.199951 | 135 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.794434 |
494 | 40.96399 | 1 | male | 1 | 7 | 7 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 26 | 93,417 | 48,108.6875 | null | 35.5 | hispanic | 35.296875 | 55 | 0.435974 | 0.234985 | 6 | 0 | 0 | no | null | null | dnr after sadm | 7 | 70 | 2.299805 | 95 | 14 | 36.69531 | 271.375 | 3.599609 | 38.398438 | 4.699219 | 136 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 3.133301 |
495 | 26.683 | 0 | female | 0 | 19 | 1,611 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 41 | 109,747 | 51,558 | null | 30 | other | 38.195313 | 48 | 0.559937 | 0.447998 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 19 | 118 | 24.097656 | 120 | 10 | 38 | 58.32812 | 2.399902 | 12.599609 | 1.399902 | 136 | 7.449219 | null | null | null | null | 0 | null | 0 |
496 | 61.85397 | 1 | female | 1 | 21 | 21 | MOSF w/Malig | ARF/MOSF | 2 | 11 | under $11k | 9 | 173,968 | 93,752.5625 | null | 23.666656 | white | 35.296875 | 78 | 0.25 | 0.145996 | 15 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 20 | 113 | 0.049995 | 180 | 28 | 39.69531 | 352.375 | 2.099609 | 2.299805 | 1.799805 | 134 | 7.549805 | null | null | null | null | null | <2 mo. follow-up | 3.466309 |
497 | 77.53595 | 1 | male | 1 | 3 | 3 | Coma | Coma | 0 | null | null | 100 | 20,078 | 9,221.7812 | null | 42 | white | 48.796875 | 67 | 0 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 40 | 10.398438 | 55 | 10 | 35.59375 | 64 | 3.899902 | 1.299805 | 2.299805 | 138 | 7.239258 | null | null | null | null | null | <2 mo. follow-up | 2.995606 |
498 | 70.03998 | 1 | female | 1 | 35 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 26 | 444,556 | 233,671.25 | null | 19.5 | white | 23.796875 | 40 | 0.555908 | 0.44397 | 14 | 0 | 0 | yes | null | null | no dnr | 35 | 93 | 10.599609 | 105 | 32 | 39 | 288 | 4.099609 | 3.599609 | 1.099854 | 132 | 7.269531 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
499 | 66.00098 | 0 | male | 0 | 7 | 1,608 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 31,463 | 15,501.3281 | null | 9 | white | 15.798828 | 40 | 0.896973 | 0.827881 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 7 | 57 | 8.699219 | 115 | 22 | 36.5 | null | 4.799805 | 0.399963 | 1.599854 | 135 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
500 | 59.995 | 1 | female | 0 | 14 | 642 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 41,479 | 17,930.9219 | null | 15.666664 | hispanic | 19.398438 | 32 | 0.861938 | 0.771973 | 1 | 0 | 0 | yes | 0.7 | 0.6 | no dnr | 14 | 77 | 4.199219 | 95 | 40 | 36.19531 | 266.625 | null | 0.099991 | 0.899902 | 133 | 7.319336 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |